Form 8-K - Current report:
SEC Accession No. 0001493152-25-013123
Filing Date
2025-09-12
Accepted
2025-09-12 06:07:02
Documents
23
Period of Report
2025-09-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 60317
2 EX-3.1 ex3-1.htm EX-3.1 2025
3 EX-10.1 ex10-1.htm EX-10.1 121071
4 EX-99.1 ex99-1.htm EX-99.1 27187
5 EX-99.2 ex99-2.htm EX-99.2 31406
6 EX-99.3 ex99-3.htm EX-99.3 97823
7 GRAPHIC form8-k_001.jpg GRAPHIC 221602
8 GRAPHIC ex3-1_001.jpg GRAPHIC 553543
9 GRAPHIC ex3-1_002.jpg GRAPHIC 897929
10 GRAPHIC ex10-1_001.jpg GRAPHIC 5093
11 GRAPHIC ex99-1_001.jpg GRAPHIC 3899
  Complete submission text file 0001493152-25-013123.txt   3160363

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE bgms-20250912.xsd EX-101.SCH 3743
13 XBRL DEFINITION FILE bgms-20250912_def.xml EX-101.DEF 26581
14 XBRL LABEL FILE bgms-20250912_lab.xml EX-101.LAB 36613
15 XBRL PRESENTATION FILE bgms-20250912_pre.xml EX-101.PRE 25205
25 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5862
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 251310002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)